Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Int J Med Inform ; 104: 120-125, 2017 08.
Article in English | MEDLINE | ID: mdl-28529113

ABSTRACT

OBJECTIVES: Many healthcare providers have implemented patient safety event reporting systems to better understand and improve patient safety. Reviewing and analyzing these reports is often time consuming and resource intensive because of both the quantity of reports and length of free-text descriptions in the reports. METHODS: Natural language processing (NLP) experts collaborated with clinical experts on a patient safety committee to assist in the identification and analysis of medication related patient safety events. Different NLP algorithmic approaches were developed to identify four types of medication related patient safety events and the models were compared. RESULTS: Well performing NLP models were generated to categorize medication related events into pharmacy delivery delays, dispensing errors, Pyxis discrepancies, and prescriber errors with receiver operating characteristic areas under the curve of 0.96, 0.87, 0.96, and 0.81 respectively. We also found that modeling the brief without the resolution text generally improved model performance. These models were integrated into a dashboard visualization to support the patient safety committee review process. CONCLUSIONS: We demonstrate the capabilities of various NLP models and the use of two text inclusion strategies at categorizing medication related patient safety events. The NLP models and visualization could be used to improve the efficiency of patient safety event data review and analysis.


Subject(s)
Drug-Related Side Effects and Adverse Reactions/prevention & control , Medication Errors/prevention & control , Natural Language Processing , Patient Safety , Pharmaceutical Preparations , Advisory Committees , Data Interpretation, Statistical , Humans , Risk Management
3.
J Heart Valve Dis ; 22(4): 599-602, 2013 Jul.
Article in English | MEDLINE | ID: mdl-24224427

ABSTRACT

The case is reported of a patient with a previously undiagnosed cause of severe congestive heart failure (CHF) caused by the presence of a discrete subaortic stenosis (SAS) from a subvalvular membrane (SVM). The clinical decision making was complicated by the concurrent presence of systolic anterior motion (SAM) of the mitral valve leaflet. Due to the limitations and eventual failure of physiologically opposing medical management strategies, the patient eventually required an open-heart surgical approach and underwent intraoperative SVM resection. A persistent intraoperative left ventricular outflow tract (LVOT) gradient of 50 mmHg due to SAM prompted mitral valve replacement, which resulted in a complete resolution of the LVOT gradient and symptoms. In this extremely rare scenario of SAS and SAM, when SVM resection is thought to be inadequate to relieve LVOT obstruction due to the concurrent presence of SAM, mitral valve replacement represents a reasonable therapeutic approach.


Subject(s)
Aortic Valve/surgery , Cardiac Surgical Procedures/methods , Discrete Subaortic Stenosis , Mitral Valve/surgery , Ventricular Outflow Obstruction/etiology , Aortic Valve/physiopathology , Discrete Subaortic Stenosis/complications , Discrete Subaortic Stenosis/diagnosis , Discrete Subaortic Stenosis/physiopathology , Discrete Subaortic Stenosis/surgery , Echocardiography, Transesophageal , Female , Heart Failure/etiology , Heart Failure/physiopathology , Humans , Intraoperative Care/methods , Middle Aged , Mitral Valve/physiopathology , Severity of Illness Index , Treatment Outcome , Ventricular Outflow Obstruction/diagnosis
4.
Seizure ; 20(10): 817-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21868257

ABSTRACT

Ictal asystole is a presumably rare but potentially fatal complication of seizures, most often of temporal lobe origin. It is believed that at least some cases of sudden unexplained death in epilepsy (SUDEP) might be triggered by ictal bradycardia or asystole. Current standard practice is to implant a permanent pacemaker in these patients to prevent syncope and/or death. However, emerging data suggests that effective medical or surgical treatment of epilepsy might be enough to prevent cardiac asystole, eliminating the need for permanent pacemaker placement. We describe a case of new onset left frontal lobe epilepsy in a young athletic patient who presented with near-syncopal episodes but whose comprehensive work-up revealed frequent events of ictal bradycardia and asystole. He responded well to monotherapy using oxcarbazepine, avoiding a permanent pacemaker.


Subject(s)
Frontal Lobe/physiopathology , Heart Arrest/etiology , Seizures/complications , Adult , Anticonvulsants/therapeutic use , Bradycardia/etiology , Carbamazepine/analogs & derivatives , Carbamazepine/therapeutic use , Electrocardiography , Electroencephalography , Humans , Male , Oxcarbazepine , Seizures/drug therapy , Seizures/physiopathology
5.
Depress Res Treat ; 2011: 795173, 2011.
Article in English | MEDLINE | ID: mdl-21197098

ABSTRACT

This longitudinal study investigates whether anhedonia and pessimistic attributional style represent a clinical state or a trait in hospitalized depressed adolescents. 81 consecutive adolescent inpatients were screened with the Beck Depression Inventory (BDI) and the clinician-rated Major Depressive Disorder (MDD) criteria sheet. 51 patients with BDI score ≥10 and/or ≥4 symptoms on MDD criteria sheet were assessed at Time 1 upon admission, with 39 patients (78%) assessed at discharge (Time 2) with the Pleasure Scale for Children and Children's Attributional Style Questionnaire-Revised. Anhedonia and pessimism at admission were associated with BDI scores at admission and discharge as well as number of depressive symptoms and depression severity. MDD diagnosis was associated with anhedonia, but not with pessimism. Pessimism-but not anhedonia-improved significantly by discharge. Results suggest that while some adolescents exhibit enduring anhedonia, pessimistic attributional style appears to be a concomitant feature of an acute depressive state.

6.
West J Emerg Med ; 11(4): 354-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21079708

ABSTRACT

OBJECTIVE: In 1996 Sgarbossa reviewed 17 ventricular-paced electrocardiograms (ECGs) in acute myocardial infarction (AMI) for signs of ischemia. Several characteristics of the paced ECG were predictive of AMI. We sought to evaluate the criteria in ventricular-paced ECGs in an emergency department (ED) cohort. METHODS: Ventricular-paced ECGs in patients with elevated cardiac markers within 12 hours of the ED ECG and a diagnosis of AMI were identified retrospectively (n=57) and compared with a control group of patients with ventricular-paced ECGs and negative cardiac markers (n=99). A blinded board certified cardiologist reviewed all ECGs for Sgarbossa criteria. This study was approved by the institutional review board. RESULTS: Application of Sgarbossa's criteria to the paced ECGs revealed the following: The sensitivity of "ST-segment elevation of 1 mm concordant with the QRS complex" was unable to be calculated as no ECG fit this criterion;For "ST-segment depression of 1 mm in lead V1, V2, or V3," the sensitivity was 19% (95% CI 11-31%), specificity 81% (95% CI 72-87%), with a likelihood ratio of 1.06 (0.63-1.64);For "ST-segment elevation >5mm discordant with the QRS complex," the sensitivity was 10% (95% CI 5-21%), specificity 99% (95% CI 93-99%), with a likelihood ratio of 5.2 (1.3 - 21). CONCLUSION: In our review of ventricular-paced ECGs, the most clinically useful Sgarbossa criterion in identifying AMI was ST-segment elevation >5mm discordant with the QRS complex. This characteristic may prove helpful in identifying patients who may ultimately benefit from early aggressive AMI treatment strategies.

7.
Toxicol Pathol ; 37(7): 902-10, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19833913

ABSTRACT

The azole antifungal drug posaconazole caused phospholipidosis in neurons of the central nervous system, dorsal root ganglia of the spinal cord, and myenteric plexus in chronic toxicity studies in dogs. The time of onset, light and electron microscopic features, neurologic and electrophysiologic effects on the central and peripheral nervous systems, and potential for regression were investigated in a series of studies with a duration of up to one year. Nuclei of the medulla oblongata were the prominently affected areas of the brain. Neurons contained cytoplasmic vacuoles with concentrically whorled plasma membrane-like material (i.e., multilamellar bodies) morphologically identical to that commonly caused in other tissues by cationic amphiphilic drugs. Some axons in the brain and spinal cord were swollen and contained granular eosinophilic, electron-dense lysosomes. There were no features suggesting degeneration or necrosis of neurons or any associated elements of nervous tissue. The earliest and most consistent onset was in neurons of dorsal root ganglia. The observed neural phospholipidosis did not result in any alteration in the amplitude or latency of the auditory, visual, or somatosensory evoked potentials. The histopathologic changes did not progress or regress within the three-month postdose period. The results indicate that phospholipidosis can be induced in central and peripheral neurons of dogs by administration of posaconazole, but this change is not associated with functional effects in the systems evaluated.


Subject(s)
Antifungal Agents/toxicity , Lipidoses/chemically induced , Neurons/drug effects , Phospholipids/metabolism , Triazoles/toxicity , Animals , Antifungal Agents/chemistry , Dogs , Ganglia, Spinal/cytology , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Medulla Oblongata/drug effects , Medulla Oblongata/ultrastructure , Myenteric Plexus/drug effects , Myenteric Plexus/metabolism , Nerve Fibers, Myelinated/drug effects , Nerve Fibers, Myelinated/ultrastructure , Neurons/cytology , Neurons/metabolism , Thalamus/cytology , Thalamus/drug effects , Thalamus/metabolism , Toxicity Tests, Chronic , Triazoles/chemistry
8.
Chest ; 134(1): 146-51, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18403670

ABSTRACT

INTRODUCTION: Pulmonary arterial hypertension (PAH) is the most common cause of scleroderma-related deaths. New medications for PAH patients make it necessary to identify patients with high risk factors for PAH. This study looks at the use of an exercise echocardiogram in identifying patients who may have PAH and may be candidates for early therapeutic intervention. METHODS: This study included 54 scleroderma patients with symptoms suggesting they were at risk for pulmonary hypertension, including dyspnea on exertion, diffusing capacity of the lung for carbon monoxide (Dlco)<60% of predicted, FVC<70% of predicted, percentage of predicted FVC/percentage of predicted Dlco (FVC%/Dlco%) ratio>1.6, or resting right ventricular systolic pressure (RVSP)>35 mm Hg. The exercise echocardiogram protocol involved the standard Bruce stress echocardiogram protocol with remeasurement of the RVSP within 1 min of stopping exercise. A positive exercise test result was defined as an increase of at least 20 mm Hg in the RVSP with exercise. Right-heart catheterization with exercise was performed in those with a positive exercise test result. RESULTS: Resting mean RVSP was 34.5 mm Hg, which increased to 51.4 mm Hg with exercise; 44% had at a positive exercise test result, which correlated with a low Dlco, high FVC%/Dlco% ratio (p<0.001), a positive anti-centromere antibody, and RVSP>35 mm Hg (p<0.05). PAH was confirmed by right-heart catheterization in 81% of patients: 19% at rest and 62% of patients with exercise. CONCLUSIONS: Exercise-induced pulmonary hypertension is a common finding in patients at high risk for PAH. This may be a sensitive way to identify patients with early PAH. Long-term follow-up and early treatment should be studied in these patients.


Subject(s)
Exercise/physiology , Hypertension, Pulmonary/diagnostic imaging , Hypertension, Pulmonary/etiology , Scleroderma, Systemic/complications , Adult , Aged , Blood Pressure/physiology , Disease Progression , Echocardiography, Doppler , Exercise Test , Female , Heart Rate/physiology , Humans , Hypertension, Pulmonary/physiopathology , Male , Middle Aged , Predictive Value of Tests , Pulmonary Artery/physiopathology , Respiratory Function Tests , Scleroderma, Systemic/physiopathology
9.
Toxicol Pathol ; 33(3): 320-8, 2005.
Article in English | MEDLINE | ID: mdl-15814361

ABSTRACT

Spontaneous hypospadias is seldom observed in rats in contrast to its occurrence in 1 out of 250 human births. Ziracin, an antibacterial of the everninomycin class under development for serious enterococcal, staphylococcal, and streptococcal infections, caused anomalies of the external genitalia in F1 female rats and decreased reproductive performance. To characterize the urogenital malformations and determine the period of sensitivity to the effects of Ziracin during development, pregnant rats (F0) were administered 60 mg/kg IV of Ziracin from GD6 to LD21, GD6 to 13, GD14 to the last day of gestation or LD0 to 21. Controls received saline or placebo from GD6 to LD21. Ziracin-induced changes occurred in F1 rats exposed from GD6 to LD21 and GD14 to the last day of gestation, indicating that the period of sensitivity to Ziracin was from GD 14 to the last day of gestation. The urogenital abnormalities consisted of cranial displacement of the urethral opening within the vagina from its normal location at the tip of the genital tubercle. When the urethrovaginal junction occurred at the distal third of the vagina, it created an urogenital cloaca. As a result, ascending infections were seen in the urinary and genital tract. No differences in survivability, body weight, and date of vaginal opening were observed in F1 females. The estrous cycles were slightly prolonged. The mating and fertility indices were decreased as a result of the urogenital anomalies. The mammary glands of pregnant F1 females were underdeveloped, thus F2 pups from affected F1 females had a decreased survival rate. Although the cause of these effects is not known, the findings are consistent with a potential hormonal mechanism.


Subject(s)
Aminoglycosides/toxicity , Genitalia, Female/pathology , Prenatal Exposure Delayed Effects , Teratogens/toxicity , Urogenital Abnormalities/pathology , Animals , Estrus/drug effects , Female , Fertility/drug effects , Genitalia, Female/drug effects , Pregnancy , Rats , Rats, Sprague-Dawley , Reproduction/drug effects , Urogenital Abnormalities/chemically induced
10.
Reprod Toxicol ; 17(6): 691-7, 2003.
Article in English | MEDLINE | ID: mdl-14613821

ABSTRACT

Normal pre- and postnatal male reproductive development and function is dependent upon testicular androgen production and is sensitive to antiandrogenic perturbations. It was of interest to determine if the H(1) histamine antagonist loratadine had the potential to alter androgen-mediated reproductive development in the rat, a sensitive species for detecting antiandrogenic effects. Loratadine was administered orally by gavage to pregnant Sprague-Dawley rats at doses of 4, 12 or 24 mg/kg from gestation day 7 to postnatal day 4, encompassing the period of androgen-dependent male reproductive development. Vehicle control rats received 0.4% aqueous methylcellulose. Dams were allowed to deliver naturally and rear their offspring until postnatal day 21. On postnatal day 21 male offspring were retained for further evaluation of androgen-dependent endpoints and the female offspring were euthanized and their sex confirmed internally. Males were necropsied from postnatal day 72 to 85. Dams administered 24 mg/kg of loratadine exhibited a transient 45% decrement in maternal body weight gain at the initiation of dosing (gestation days 7-9). Mean pup body weight on postnatal days 1 and 4 were approximately 4% lower than controls. No other effects on offspring growth were observed. Anogenital distance on postnatal day 1 was unaffected by loratadine exposure. Loratadine exposure did not induce the retention of nipples in male rats, affect preputial separation, or induce external malformations, including hypospadias. Seminal vesicle and prostate weights were not decreased by loratadine exposure. These data clearly demonstrate that systemic loratadine exposure, in multiples up to 26 times clinical exposure levels, does not exhibit in vivo antiandrogen activity, as evidenced by the absence of alterations or malformations in androgen-dependent reproductive tissues in male rats exposed to loratadine during the critical period of androgen-dependent development.


Subject(s)
Genitalia/drug effects , Histamine H1 Antagonists/toxicity , Loratadine/toxicity , Androgens/physiology , Animals , Birth Weight/drug effects , Body Weight/drug effects , Endpoint Determination , Female , Fetal Death/chemically induced , Fetal Death/epidemiology , Lactation , Litter Size , Male , Organ Size/drug effects , Pregnancy , Prenatal Exposure Delayed Effects , Rats , Sex Ratio , Sexual Maturation/drug effects , Sucking Behavior/physiology
11.
J Trauma Stress ; 15(1): 77-85, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11936725

ABSTRACT

This study evaluated children's symptoms 3 and 9 months after the 1993 bombing of the World Trade Center, and the relationship between parent and child reactions when only the children had been in the building. Nine children who had been trapped in an elevator, 13 who had been on the observation deck, and 27 controls completed the Posttraumatic Stress Reaction Index and a Fear Inventory. Parents completed these measures about the children and comparable measures about themselves. Exposed children reported posttraumatic stress disorder (PTSD) symptoms and disaster-related fears; their parents reported experiencing PTSD symptoms. Only parents rated children's symptoms as decreasing significantly over time. Association between child symptoms and parent symptoms increased over time. Children's initial distress predicted parents' distress 9 months postdisaster.


Subject(s)
Explosions , Fear/psychology , Stress Disorders, Post-Traumatic/etiology , Terrorism/psychology , Adult , Child , Female , Follow-Up Studies , Humans , Male , New York City , Parent-Child Relations , Prognosis , Stress Disorders, Post-Traumatic/psychology , Time Factors
12.
Toxicol Sci ; 65(2): 256-65, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11812930

ABSTRACT

Adenoviral vectors are being actively investigated for their potential utility in gene therapy. SCH 58500, a replication-deficient adenoviral vector, carries the normal p53 tumor suppressor gene, which is frequently mutated or absent in several human cancers. To assess the potential toxicity associated with adenoviral use, Yorkshire pigs were dosed by intravenous, intrahepatic, or local routes (subcutaneous and intradermal) to support a variety of potential clinical indications. Porcine cells were shown to support replication of wild-type human adenovirus. The nonlethal and asymptomatic dose in pigs following dosing via the intrahepatic route was greater than 3 x 10(8) plaque-forming units (pfu)/kg (2.2 x 10(11) particles/kg), but less than 2.1 x 10(9) pfu/kg (1.5 x 10(12) particles/kg). By the intravenous route it was 1 x 10(8) pfu/kg, and by the ip route it was greater than or equal to 3 x 10(8) pfu/kg. In a multicycle intraperitoneal study in pigs, the high dose of 3 x 10(8) pfu/kg caused an increased antibody and/or an inflammatory response. By the intravenous route, plaque-forming units were present in most pigs at 5 min postdose, but only in a few at 10 min postdose. No expression was found in gonadal tissue approximately 3 weeks after a single intravenous injection of 3 x 10(8) pfu/kg. At high intrahepatic doses (about 1.5 x 10(12) particles/kg), acute cardiovascular and hemodynamic effects were found, which in subsequent studies were also present at high doses by intravenous administration. Based on these findings, careful evaluation of hemodynamic parameters in patients receiving systemic doses of SCH 58500 is warranted.


Subject(s)
Adenoviridae/genetics , Genes, p53 , Genetic Vectors/toxicity , Animals , Antibodies, Viral/blood , Cardiovascular System/drug effects , Cardiovascular System/physiopathology , DNA, Viral/analysis , Defective Viruses , Dose-Response Relationship, Drug , Drug Administration Routes , Erythrocytes/immunology , Female , Hemagglutination Tests , Hemodynamics/drug effects , In Vitro Techniques , Macaca mulatta , Male , Mice , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Safety , Swine , Toxicity Tests
13.
Toxicol Sci ; 65(2): 266-75, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11812931

ABSTRACT

SCH 58500 is a replication-defective recombinant adenoviral vector containing the cloned human wild-type (normal) tumor suppressor gene p53. SCH 58500 is in trials to evaluate potential clinical utility. A series of toxicology studies in rats and mice were conducted via multiple routes of exposure to support these programs. The nonlethal and asymptomatic dose in rats following a 14-day observation period was equal to 7.5 x 10(7) plaque-forming units (pfu)/kg (5.6 x 10(10) particles/kg) by intravenous or intraperitoneal route and was similar by the ip route, following 4 weeks of dosing. The high dose of 1.5 x 10(9) pfu/kg (1.1 x 10(12) particles/kg) was lethal by the i.v. route and inflammatory to the peritoneal cavity by the ip route. SCH 58500 was rapidly cleared from the systemic circulation in rats (serum t(1/2) of 7 to 9 min) following iv administration. Administration by other routes resulted in no (sc) or delayed (ip) serum levels. Since most rats in the i.v. rat study died within 24 h postdose, another study to evaluate potential mechanisms of toxicity in rats was designed in which rats were killed at intervals following a single i.v. dosing. A single high i.v. dose of SCH 58500 (1.1 x 10(12) pfu/kg) was associated with lethargy, soft feces, a ruffled-hair coat, and death within 1 h postdose. Potential mechanisms of toxicity appeared to include a mild coagulopathy and/or vasculopathy, resulting in consumption of platelets and clotting factors, leakage or loss of intravascular fluid, hemoconcentration, electrolyte and/or fluid shifts, a moderate stress and/or inflammatory response, and a mild, direct or indirect toxic effect on liver and/or kidney tissue. These findings suggest a multifocal cause for acute lethality following i.v. dosing in rats.


Subject(s)
Adenoviridae/genetics , Genes, p53 , Genetic Vectors/toxicity , Adenoviridae/growth & development , Animals , Antibodies, Viral/blood , Blood Coagulation/drug effects , Defective Viruses , Dose-Response Relationship, Drug , Female , Hemagglutination Tests , Kidney/drug effects , Liver/drug effects , Male , Mice , Mice, Inbred ICR , Rats , Rats, Sprague-Dawley , Safety , Toxicity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...